Post Hoc Analysis of Phase III Gecacitinib Clinical Trial Outcomes: Enhanced Understanding and Implications

被引：0

作者：

Zhang, Yi ^{[1
]}

Zhou, Hu ^{[2
]}

Suo, Shanshan ^{[1
]}

Zhuang, Junling ^{[3
]}

Yang, Linhua ^{[4
]}

He, Aili ^{[5
]}

Liu, Qingchi ^{[6
]}

Du, Xin ^{[7
]}

Gao, Sujun ^{[8
]}

Li, Yarong ^{[9
]}

Li, Yan ^{[10
]}

Chen, Yuqing ^{[11
]}

Wu, Wen ^{[12
]}

Zhu, Huanling ^{[13
]}

He, Guangsheng ^{[14
]}

Hong, Mei ^{[15
]}

Jiang, Qian ^{[16
]}

Jiang, Zhongxing ^{[17
]}

Jing, Hongmei ^{[18
]}

Wang, Jishi ^{[19
]}

Xu, Na ^{[20
]}

Yue, Lingling ^{[21
]}

Zheng, Cuiping ^{[22
]}

Zhou, Zeping ^{[23
]}

Jin, Chenghao ^{[24
]}

Li, Xin ^{[25
]}

Liu, Lin ^{[26
]}

Xu, Yajing ^{[27
]}

Wu, Dengshu ^{[28
]}

Zhang, Feng ^{[29
]}

Zhang, Jin ^{[30
]}

Xiao, Zhijian ^{[31
]}

Jin, Jie ^{[1
]}

机构：

[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China

[2] Henan Prov Hematol Hosp, Dept Hematol, Zhengzhou, Henan, Peoples R China

[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China

[4] Second Hosp Shanxi Med Univ, Neurosurg, Taiyuan, Peoples R China

[5] Xi An Jiao Tong Univ, Dept Neurol, Affiliated Hosp 2, Xian, Peoples R China

[6] Hebei Med Univ, Hosp 1, Shijiazhuang, Peoples R China

[7] Southern Med Univ, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Dept Hematol, Guangzhou, Peoples R China

[8] First Hosp Jilin Univ, Dept Hematol, Changchun, Peoples R China

[9] Second Hosp Jilin Univ, Dept Hematol & Oncol, Changchun, Peoples R China

[10] China Med Univ, Affiliated Hosp 1, Dept Hematopathol, Shenyang, Peoples R China

[11] Henan Prov Peoples Hosp, Dept Hematol, Zhengzhou, Peoples R China

[12] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, State Key Lab Med Genom,Ruijin Hosp,Sch Med, Shanghai, Peoples R China

[13] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China

[14] Nanjing Med Univ, Key Lab Hematol, Jiangsu Prov Hosp, Collaborat Innovat Ctr Canc Personalize,Affiliated, Nanjing, Peoples R China

[15] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[16] Peking Univ, Inst Hematol, Natl Clin Res Ctr Hematol Dis, Peoples Hosp, Beijing, Peoples R China

[17] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[18] Peking Univ Third Hosp, Beijing, Peoples R China

[19] GuiZhou Med Univ, Dept Hematol, Affiliated Hosp, Guiyang City, Peoples R China

[20] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China

[21] Lanzhou Univ Second Hosp, Dept Hematol & Oncol, Lanzhou, Peoples R China

[22] Wenzhou Cent Hosp, Dept Oncol 2, Wenzhou, Peoples R China

[23] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China

[24] Jiangxi Prov Peoples Hosp, Nanchang, Peoples R China

[25] Cent South Univ, Third Xiangya Hosp, Dept Hematol, Changsha, Peoples R China

[26] Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China

[27] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[28] Cent South Univ, Xiangya Hosp, Dept Hematol, Changsha, Peoples R China

[29] Bengbu Med Coll, Affiliated Hosp 1, Dept Hematol, Bengbu, Peoples R China

[30] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Hematol, Hangzhou, Peoples R China

[31] Chinese Acad Med Sci & Peking Union Med Coll, MDS & MPN Ctr, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-202790

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3165 / 3166

页数：2

共 50 条

[21] Early mucosal healing at week, 10 with ozanimod predicts clinical outcomes at week, 52: Post hoc analysis of the phase, 3 True North clinical trial
Reinisch, W.
Axelrad, J.
Ahmad, H. A.
Pondel, M.
Ather, S.
Elegbe, A.
Sninsky, C.
Longman, R.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I415 - I415
[22] Early mucosal healing at week, 10 with ozanimod predicts clinical outcomes at week, 52: Post hoc analysis of the phase, 3 True North clinical trial
Reinisch, W.
Axelrad, J.
Ahmad, H. A.
Pondel, M.
Ather, S.
Elegbe, A.
Sninsky, C.
Longman, R.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I415 - I415
[23] Intraventricular Hemorrhage Expansion in the CLEAR III Trial: A Post Hoc Exploratory Analysis
Roh, David J.
Asonye, Ifeyinwa S.
Poyraz, Fernanda Carvalho
Magid-Bernstein, Jessica R.
Joiner, Evan F.
Avadhani, Radhika
Awad, Issam
Hanley, Daniel F.
Ziai, Wendy C.
Murthy, Santosh B.
STROKE, 2022, 53 (06) : 1847 - 1853
[24] Investigating the trends in patient-reported outcomes pre-treatment and implications to efficacy analyses: A post-hoc analysis of a cancer clinical trial
Schlichting, Michael
Sanz, Hector
Williams, Paul
Ballarini, Nicolas
Rippin, Gerd
Pawar, Vivek
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 30
[25] Intravenous fluids for migraine: a post hoc analysis of clinical trial data
Balbin, Jerome Edward B.
Nerenberg, Rebecca
Baratloo, Alireza
Friedman, Benjamin W.
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (04): : 713 - 716
[26] Baseline Predictors of Clinical Response: A Post Hoc Analysis of the Ambition Trial
Benza, Raymond
Blair, Christiana
Patel, Krishna
Eads, Michael
CHEST, 2017, 152 (04) : 1052A - 1052A
[27] EFFECT OF VITAMIN D SUPPLEMENTATION ON CLINICAL OUTCOMES IN PATIENTS WITH CIRRHOSIS: A POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
Grover, Indu
Sharma, Sanchit
Madhu, Deepak
Agarwal, Samagra
Singh, Namrata
Gunjan, Deepak
Saraya, Anoop
HEPATOLOGY, 2021, 74 : 1213A - 1214A
[28] Clinical Severity and Outcomes in Large Infarcts With Endovascular Therapy: A Post Hoc Analysis of the ANGEL-ASPECT Trial
Lu, Qixuan
Zheng, Lina
Nie, Ximing
Wang, Mengxing
Duan, Wanying
Liu, Xin
Zhang, Zhe
Wen, Miao
Yang, Zhonghua
Leng, Xinyi
Pan, Yuesong
Nguyen, Thanh N.
Liu, Liping
STROKE, 2025, 56 (04) : 1048 - 1053
[29] Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial
Han, MeiLan K.
Criner, Gerard J.
Halpin, David M. G.
Kerwin, Edward M.
Tombs, Lee
Lipson, David A.
Martinez, Fernando J.
Wise, Robert A.
Singh, Dave
CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2024, 11 (01): : 106 - 113
[30] Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial
Constantin, Arnaud
Caporali, Roberto
Edwards, Christopher J.
Fonseca, Joao Eurico
Iannone, Florenzo
Keystone, Edward
Schulze-Koops, Hendrik
Kwon, Taek
Kim, Seungmin
Yoon, SangWook
Kim, Dong-Hyeon
Park, Gahee
Yoo, Dae Hyun
RHEUMATOLOGY, 2023, 62 (08) : 2838 - 2844

← 1 2 3 4 5 →